Atlas Concussion Testing utilizes a combination of gait, balance, VOMS and neurocognitive tests developed by SportGait as concussion baseline testing. The highly specialized tests are designed to evaluate specific brain regions and their associated functions, such as memory, cognition, planning, decision making and mood (personality). These functions have been documented as the primary signs and symptoms related to concussion injuries and post-concussion syndrome. These tests are provided as a set and may be completed on any computer either in person or by app, and the session only takes about 10 minutes. Baseline testing results are stored indefinitely and may be compared with similar future tests for concussion injury evaluation.
Atlas Concussion Testing also offers exclusive serum biomarker testing developed by Cyrex Labs in 2016 that measure Blood Brain Barrier Permeability proteins. As a baseline test, these biomarkers offer objectivity at the most discrete level. Like Dr. Alden often says, "The blood doesn't lie". This blood test is designed to identify antibodies that are present while the blood brain barrier remains disrupted after a concussion injury has occurred. Therefore, when baseline results are recorded with NO antibodies present, a follow-up blood test may be performed after a concussion injury and if there are measurable biomarkers, then confirmation of the mild Traumatic Brain Injury is available for physicians and other caregivers. This level of objectivity takes the guesswork out of confirming the diagnosis.
Atlas Concussion Testing also offers exclusive serum biomarker testing developed by Cyrex Labs in 2016 that measure Blood Brain Barrier Permeability proteins. As a baseline test, these biomarkers offer objectivity at the most discrete level. Like Dr. Alden often says, "The blood doesn't lie". This blood test is designed to identify antibodies that are present while the blood brain barrier remains disrupted after a concussion injury has occurred. Therefore, when baseline results are recorded with NO antibodies present, a follow-up blood test may be performed after a concussion injury and if there are measurable biomarkers, then confirmation of the mild Traumatic Brain Injury is available for physicians and other caregivers. This level of objectivity takes the guesswork out of confirming the diagnosis.
